绝经妇女相关指标含量的测定对骨质疏松的临床诊断价值

13220005JournalofIsotopesVol.13No.2May2000,,,,,(,400042):;;;;:R817148:A:100027512(2000)0220126203,(Osteoporosis,OP)OP[1]1941Albright(PostmenopanseOsteoporosis,PMO),PMO1992119991398(E2FSH)(GH)(AKP)CaP,AKPCaP1111,398117,4454,61281,4570,620;,3:6111212330,2334,1112GH;;CX4CX3217197,:1999201211;:2000204203:(1952),(),,,(RIA);AKP;Ca;Pxqs,t331111,E2GH,P0101;FSH,P0105E2GH(P0101)FSH(P0105)FSHE2,FSHE2E2GH(r=0.3842,y=0.99250.039x,P0.05)1(xqs)E2öngL-1FSHöIUL-1GHöLgL-130109.9554.818.424.833.020.6211796.2174.0612.092.731.960.676110827.4823.8180.6719.681.360.561129531.1925.7951.1212.512.060.53127820.7018.5380.7923.371.070.3531222,()AKP(P0101),AKP(P0105)PCa(P0105)122(xqs)AKPöIUL-1CaömmolL-1PömmolL-13044.699.632.250.180.990.1011759.1918.532.250.251.020.196110883.8030.872.190.191.090.131129582.5536.932.250.161.030.17127882.7527.222.260.251.240.257212:4411E2FSHGH1FSH,,FSH,E2,FSHE2,[2,3]GH191(IGF21)[4],,GH;,GH,IGF21,IGF21,GH[5]412AKP,,AKP[6]2,AKPP0105,,,,,2[7]413CaP[8]Ca,P,2CaP,,5,PO,,E2FSHGHAKP,PMO:[1],,,1[M]1:,199515475511[2],,,1[J]1,1993,19(6):3033041[3]1[J]1,1992,7(1):28301[4]GrowthBR.HormoneandBone[J].HormRes,1990,36(1):4955.[5]WeissbergerAJ,HokkLazarasL.ContrastingEffectsofTransdermalRoutesofEstrogenReplacementTherapyon24hourGrowthHormoneSecretionInsulinlikeGrouthFacter1andGHBindingProteininPostmenopausalWomen[J].JClinEndocrinalMetab,1991,72(2):374381.[6]FurmarAM,MeidrumOR,GeolaF,etal.RelationshipofFastingUrinarytoCirculatingandBodyWeightinPostmenopausalWomen.[J].JClinEndocinolMetab,1980,5:70.[7]1[M].:,198912623061[8],,,1[J]1,1993,13(3):160161182113